- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02653040
Light as an Aid for Recovery in Psychiatric Inpatients
Light as an Aid for Recovery in Psychiatric Inpatients: A Pragmatic Randomized Controlled Pilot Trial
Study Overview
Detailed Description
Setting: 17 bed inpatient ward at a University Mental Health Hospital
Rooms: The dimensions of all 17 rooms are identical with 4,54m x 3,14m, ceiling height 3,15m, a window, a bed, a table, a chair and a bathroom 1,55m x 1,85m.
Assignment of interventions: After admission patients are invited to participate in the study. If the patients wish to participate they will go through eligibility screen, sign informed consent and fill out questionnaires on sleep, mood and well-being (-t1). The patients (now participants) are randomly allocated (t0) by sealed envelope technique and the envelope is brought to the staff office and opened by a staff member who then from the computer in the office programs the participant's room to either intervention or control.
Randomization: The investigators used random permuted blocks of varying and blinded block size. A third party person created the envelopes and arranged them in blocks.
Blinding: The outcome assessor and data analyst is blinded to allocation. Trial participants and care providers are unblinded. Participants may be replaced to another room for practical, clinical reasons. In this case, the intervention/control conditions will follow the patient.
Data management: All data will be entered in RedCAP and stored in a electronic online secured database at Aarhus University.
Power estimation: Alfa: 0.05. Beta: 0.20. Effect size: change of 4 points in PSQI with a standard deviation estimated to 4. Number of patients in each arm: 17 (x 2 = 34). Number needed to be included accounting for discontinuation: 60 (estimated)
Statistics: The investigators will calculate intention-to-treat. Other statistical analyses will include logistic regression for dichotomous outcome data, analysis of covariance for continuous outcome data, and survival analysis for time-to-event outcome data. Interim-analyses during the data-collection period to stop trial if intervention produces larger than expected benefits or harm or if investigators find evidence of no important difference between experimental and control interventions.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Jylland
-
Risskov, Jylland, Denmark, 8240
- Department of Affective Disorders, Aarhus University Hospital, Risskov
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Admission
Exclusion Criteria:
- Inability to provide written consent
- Mania
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dynamic lighting
Indoor lighting with low-lux no-blue wavelengths at night.
|
Intervention is rooms with light settings imitating natural light conditions with white light at day and low-lux no-blue light at night: 07am-10am: white light, increasing intensity 10am-07pm: white light, full intensity 07pm-11pm: no blue wavelength, low intensity 11pm-07am: no blue wavelength, very low intensity
Other Names:
|
|
No Intervention: Treatment as usual
Characterized by full white light with little variation through a day cyclus.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Sleep quality on the Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
|
Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive symptoms on the Major depression inventory (MDI)
Time Frame: Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
|
Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
|
|
|
Well-being on the World Health Organization measure of well-being (WHO-5)
Time Frame: Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
|
Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
|
|
|
Qualitative assessment using a custom made questionnaire
Time Frame: Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
|
Number of patients with side-effects.
|
Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
|
|
Sleep diary
Time Frame: Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
|
Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to discharge
Time Frame: Assessed through study completion, an average of 1 month, up to 6 months
|
Number of days between admission and discharge
|
Assessed through study completion, an average of 1 month, up to 6 months
|
|
Involuntary restraints
Time Frame: Assessed through study completion, an average of 1 month, up to 6 months
|
Number of participants who experienced involuntary physical and/or medical restraints.
|
Assessed through study completion, an average of 1 month, up to 6 months
|
|
Use of medication from logged activity in the electronic medical record
Time Frame: Assessed through study completion, an average of 1 month, up to 6 months
|
Use of medication during admission including drug og dosages administered to the participants in mg/day.
|
Assessed through study completion, an average of 1 month, up to 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Niels Okkels, MD, Aarhus University Hospital
Publications and helpful links
General Publications
- LeGates TA, Fernandez DC, Hattar S. Light as a central modulator of circadian rhythms, sleep and affect. Nat Rev Neurosci. 2014 Jul;15(7):443-54. doi: 10.1038/nrn3743. Epub 2014 Jun 11.
- Bedrosian TA, Nelson RJ. Influence of the modern light environment on mood. Mol Psychiatry. 2013 Jul;18(7):751-7. doi: 10.1038/mp.2013.70. Epub 2013 May 28.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- QLIGHT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Illness
-
Education University of Hong KongBaptist Oi Kwan Social ServiceCompletedSevere Mental IllnessHong Kong
-
New York UniversityUniversity of Pennsylvania; Yale UniversityCompleted
-
University of OklahomaCompleted
-
University of Illinois at ChicagoNational Institute on Disability, Independent Living, and Rehabilitation... and other collaboratorsCompletedMental Illness Persistent
-
Queen's UniversityCompletedSerious Mental Illness
-
Oulu University HospitalUniversity of OuluRecruiting
-
University of GroningenLentis Psychiatric Institute; GGZ Friesland; Stichting CosisRecruitingSevere Mental IllnessNetherlands
-
Shalvata Mental Health CenterRecruitingSevere Mental IllnessIsrael
-
VA Office of Research and DevelopmentWithdrawn
-
Indiana UniversityCompleted
Clinical Trials on Dynamic lighting
-
Well Living Lab, Inc.Mayo ClinicRecruitingPhysical Activity | Sleep | Cognitive Function | Social IsolationUnited States
-
Lund UniversityAFA InsuranceRecruitingWell-being | Sleep Quality | Cortisol | Melatonin | Energy LevelsSweden
-
Arizona State UniversityArizona Alzheimer's Consortium; Arizona State University Knowledge EnterpriseCompleted
-
Maastricht University Medical CenterPhilips Lighting EindhovenCompleted
-
Icahn School of Medicine at Mount SinaiCompletedSleep Disturbance | Alzheimer's DiseaseUnited States
-
Icahn School of Medicine at Mount SinaiCompletedAlzheimer's DiseaseUnited States
-
Arizona State UniversityWithdrawnSleep | Alertness | Daytime Cognitive Performance
-
Wake Forest University Health SciencesCompletedColorectal Cancer Screening | Colon Adenomatous PolypUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)CompletedMild Cognitive Impairment | Alzheimer's DiseaseUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)Completed